Konstantinos Spengos Selected Research

Antibodies

3/2012	Pretreatment antibodies against acid α-glycosidase in a patient with late-onset Pompe disease.
11/2008	Sarcoidosis in a case of MuSK-positive myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Spengos Research Topics

Disease

16	Stroke (Strokes) 12/2021 - 03/2003
9	Ischemic Stroke 01/2021 - 12/2004
5	Atrial Fibrillation 10/2018 - 01/2005
3	Transient Ischemic Attack 01/2021 - 12/2004
3	Glycogen Storage Disease Type II (Pompe's Disease) 03/2012 - 11/2011
2	Atherosclerosis 01/2021 - 01/2013
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2016 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2016 - 08/2011
2	Muscular Diseases (Myopathy) 07/2015 - 07/2006
2	Myasthenia Gravis 11/2008 - 02/2008
2	Thromboembolism 01/2006 - 12/2004
1	Infarction (Infarctions) 12/2021
1	Brain Ischemia (Cerebral Ischemia) 12/2017
1	Thalassemia 12/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Coronary Disease (Coronary Heart Disease) 05/2016
1	1 Rippling muscle disease 07/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2015
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 07/2015
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2015
1	Brain Infarction 01/2015
1	Pathologic Constriction (Stenosis) 01/2015
1	Cardiomyopathies (Cardiomyopathy) 07/2014
1	Arthralgia (Joint Pain) 01/2014
1	Exanthema (Rash) 01/2014
1	Hypertension (High Blood Pressure) 01/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Dyskinesias (Dyskinesia) 12/2012
1	Hypoglycemia (Reactive Hypoglycemia) 12/2012
1	Hyperglycemia 12/2012
1	Femoral Neuropathy 05/2012
1	Late Onset Disorders 01/2012
1	Fatigue 01/2012
1	Myocardial Infarction 08/2011
1	Unstable Angina 08/2011
1	Rupture 08/2011
1	Aortic Aneurysm (Aneurysm, Aortic) 08/2011
1	Sudden Death 08/2011
1	Thoracic Aortic Aneurysm 06/2011
1	Neurofibromatoses (Neurofibromatosis) 06/2011
1	Neoplasms (Cancer) 06/2011
1	Moyamoya Disease (Moya-Moya Disease) 06/2011
1	Down Syndrome (Down's Syndrome) 06/2011
1	Sarcoidosis (Schaumann Disease) 11/2008
1	Pulmonary Sarcoidosis 11/2008
1	Facial Hemiatrophy (Parry-Romberg Syndrome) 06/2008
1	Thrombosis (Thrombus) 02/2008
1	Thymus Hyperplasia 02/2008

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2018 - 12/2004
3	AnticoagulantsIBA 10/2018 - 01/2005
3	Clopidogrel (Plavix)FDA Link 12/2017 - 08/2011
3	Warfarin (Coumadin)FDA LinkGeneric 05/2012 - 12/2004
3	Glycoside Hydrolases (Endoglycosidases)IBA 03/2012 - 11/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 07/2015 - 07/2006
2	AntibodiesIBA 03/2012 - 11/2008
2	AcidsIBA 03/2012 - 11/2011
2	GlycogenIBA 01/2012 - 11/2011
2	muskIBA 11/2008 - 02/2008
1	LipidsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 06/2018
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Integrin beta3 (GPIIIa)IBA 05/2016
1	Apolipoproteins E (ApoE)IBA 05/2016
1	ApolipoproteinsIBA 05/2016
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2016
1	triflusalIBA 01/2016
1	Cilostazol (Pletal)FDA LinkGeneric 01/2016
1	TicagrelorIBA 01/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Caveolin 3IBA 07/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	cysteine and glycine-rich protein 3IBA 07/2014
1	Antinuclear AntibodiesIBA 01/2014
1	danaparoid (Orgaran)FDA Link 04/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Insulin (Novolin)FDA Link 12/2012
1	Estrogen Receptor betaIBA 05/2012
1	Estrogen Receptor alphaIBA 05/2012
1	Sertraline (Zoloft)FDA LinkGeneric 01/2012
1	Antidepressive Agents (Antidepressants)IBA 01/2012
1	Citalopram FDA LinkGeneric 01/2012
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2012
1	4-O-carboxymethylascochlorinIBA 08/2011
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 06/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2008
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 06/2008
1	Prednisone (Sone)FDA LinkGeneric 02/2008
1	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2008
1	N-Methylaspartate (NMDA)IBA 02/2008

Therapy/Procedure

10	Therapeutics 01/2016 - 01/2002
5	Secondary Prevention 01/2016 - 01/2005
2	Enzyme Replacement Therapy 01/2012 - 11/2011
2	Radiotherapy 06/2011 - 08/2006
1	Telescopes 12/2021
1	Thrombectomy 03/2018
1	Duration of Therapy 01/2012
1	Thymectomy 02/2008